Search Results

Displaying Results 2876-2900 of 26720 "'D'"

Aug 12, 2026, 11:00 ET DESLOC V150 Plus Solar Smart Lock Tops $500,000 on Kickstarter, Setting a New Smart Lock Crowdfunding Milestone

these technologies allow the lock to collect energy from ambient light and use it to help support everyday operation.The V150 Plus also features 3D facial recognition, curved fingerprint recognition, built-in Wi-Fi, door-status detection and app-based remote management. The goal is to provide convenient

More news about: DESLOC


Aug 12, 2026, 10:45 ET Breakthrough T1D Run 2026-2027 Season Launches, Uniting Runners Worldwide to Fund Type 1 Diabetes Research

/PRNewswire/ -- Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, has launched its 2026-2027 Breakthrough T1D Run season to bring the community together and raise awareness and funds for critical T1D research. Breakthrough T1D Run is a powerful movement

More news about: Breakthrough T1D, Formerly JDRF


Aug 12, 2026, 10:44 ET GACC™ Closes $34 Million Credit Facility for Flexible Packaging Manufacturer

financial flexibility that will support this company's next phase of growth."About GACC™Great American Capital Corporation, LLC, d/b/a GACC, is an asset-based lending platform designed to provide flexible capital solutions to mid-market companies with strong underlying collateral

More news about: Great American Holdings, LLC


Aug 12, 2026, 10:09 ET REGN DEADLINE: Levi & Korsinsky Reminds Regeneron Pharmaceuticals, Inc. Investors of Upcoming Securities Class Action Deadline

Senior Officer Securities Liability Section 20(a) Control Person AllegationsThe complaint names Regeneron and individual defendants George D. Yancopoulos, Co-Founder, President, Chief Executive Officer and Co-Chairman, Israel Lowy, Senior Vice President and Clinical Development Unit Head of

More news about: Levi & Korsinsky, LLP


Aug 12, 2026, 10:07 ET MGN Shareholder Alert: Megan Holdings Limited Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky

Statement permitting the Company to issue 1,250,000 ordinary shares at an initial offering price of $4.00 per share, raising $5,000,000 in gross proceeds. D. Boral Capital LLC served as the sole bookrunning manager and underwriter on a firm commitment basis.The Prospectus described Megan as "a company

More news about: Levi & Korsinsky, LLP


Aug 12, 2026, 10:01 ET Cancer Tumor Profiling Market worth $19.87 billion by 2031 - Exclusive Report by MarketsandMarkets™

Technology (Omics, Imaging), Cancer (Lung, Breast, Leukemia, Melanoma, Colorectal), Product (Instruments, Consumables), Application (Diagnostics, R&D, Prognostics), End user, and Region - Global Forecast to 2032

More news about: MarketsandMarkets


Aug 12, 2026, 09:19 ET 퀀티넘, 2026년 2분기 실적 발표

퀀티넘의 사장인 라지브 하즈라(Rajeeb Hazra) 최고경영자(CEO)는 "2분기 실적은 당사의 전략에 따른 강력한 실행력을 보여줬다. 플랫폼 로드맵을 진전시키고 경쟁력을 강화하기 위한 핵심 연구개발(R&D) 성과를 달성했으며, 공급망과 제조 역량을 강화하고 개발자 생태계 참여도도 확대했다"면서 "그 결과 사업의 상업화 모멘텀이 가속화되고 있으며, 이는 2분기 실적과 상향된 연간 전망에 반영됐다. 20억 달러가 넘는 현금을 보유한 만큼 장기적으로 지속 가능한 성장과

More news about: Quantinuum


Aug 12, 2026, 09:14 ET Borr Drilling Limited - Q2 2026 Presentation

https://mb.cision.com/Public/16983/4382581/a3ad86d034688c66.pdfBorr Drilling

More news about: Borr Drilling Limited


Aug 12, 2026, 09:01 ET Propel Bio Partners Highlights Progress of EIT Pharma Under Leadership of CEO Dr. Leen Kawas

hepatitis D (CHD), and Lambda, its Phase 2 investigational treatment for severe acute viral respiratory infections. FDA recently accepted Lonafarnib's New Drug Application which follows Lonafarnib completing its D-LIVR study, the largest clinical trial conducted to date in chronic hepatitis D, which enrolled

More news about: Propel Bio Partners


Aug 12, 2026, 09:00 ET Lam Research and NY Creates Team Up to Enable Training of University Students for the Semiconductor Workforce

organization that owns and operates the Albany NanoTech Complex, the most advanced nonprofit-led 300m semiconductor R&D site in North America. The program will use Lam's SEMulator3D® virtual fabrication software, part of the Semiverse ® Solutions portfolio, to deliver hands-on learning

More news about: Lam Research Corporation


Aug 12, 2026, 09:00 ET Reudyn Launches Wearable Robotics Brand Focused on Human-Centered Mobility

Wearability TogetherReudyn has assembled a multidisciplinary R&D team spanning intelligent power systems, adaptive algorithms, human-machine interaction, human factors engineering and materials engineering.The core R&D team is led by researchers with advanced academic backgrounds and

More news about: Reudyn


Aug 12, 2026, 09:00 ET Viome Acquires Circulate Health, Closing the Loop Between Early Diagnostics, Precision Nutrition, and Treatment

develop non-invasive early detection tests for high-mortality cancers and chronic diseases.ReferencesFuentealba M, Kiprov D, Schneider K, et al. Multi-Omics Analysis Reveals Biomarkers That Contribute to Biological Age Rejuvenation in Response to Single-Blinded Randomized

More news about: Viome Life Sciences


Aug 12, 2026, 09:00 ET PATRÓN® TEQUILA CONTINUES ITS TRANSPARENCY CAMPAIGN, ASKING DRINKERS WHAT'S ACTUALLY IN THEIR TEQUILA

Grand Central and Times Square, along with can't miss media placements encompassing the entire Times Square 1/2/3 station. There are also eye-popping 3-D billboards, with one location at 7th Ave and 33rd Street in Manhattan and the other in Los Angeles on Sunset Boulevard in West Hollywood.Some of

More news about: Patron Tequila


Aug 12, 2026, 09:00 ET Clearwave Launches AI Patient Engagement Platform: An Agentic Workforce for the Industry's Most Manual Work

than 'AI hype' – it needs Clearwave's special healthcare knowledge, data, staff training, ruleset and workflow experience – combined with leading R&D. As a result, we're now offering AI agents that let organizations grow without adding complexity or headcount," said Mike Coffey, Chief Executive Officer

More news about: Clearwave, Inc.


Aug 12, 2026, 08:49 ET Strativera Now Credentialed Across Both Major CRM Ecosystems as Salesforce Listing Goes Live

https://appexchange.salesforce.com/appxListingDetail?listingId=2767129d-ff82-4774-871e-136a99f7ca04, and the HubSpot Solutions Partner listing at

More news about: Strativera


Aug 12, 2026, 08:39 ET TCL CSOT Advances Into Professional Esports and Powers the Future of AI Computing at ChinaJoy 2026

begun preliminary research and technical feasibility studies on glass substrates while actively evaluating project construction and collaborative R&D with customers.

More news about: TCL CSOT


Aug 12, 2026, 08:34 ET NABJ26 Unveils Signature Events Lineup: A Week of Honors, Wellness, Entertainment and Celebration in Atlanta

note of reflection and renewal with Gospel Brunch, from 9:00 a.m. to 11:00 a.m. Atlanta native and proud NABJ member Rev. Dr. Mashaun D. Simon delivers an uplifting message, hosted by local meteorologist Jonathan Stacey Radford, with a musical performance by national recording

More news about: National Association of Black Journalists


Aug 12, 2026, 08:33 ET Londian Wason, líder mundial en láminas de cobre, anuncia el precio de su oferta pública inicial ampliada

EBITDA ajustado alcanzó los 868,851 millones de RMB (unos 124,244 millones de dólares estadounidenses). En términos de I+D, al 31 de diciembre de 2025, la compañía contaba con un equipo de I+D dedicado de 428 profesionales, con 634 patentes registradas y 168 solicitudes de patente pendientes en China. También

More news about: LONDIAN WASON NEW ENERGY TECH INC.


Aug 12, 2026, 08:30 ET Insilico Medicine Nominates ISM0900, a Potent, AI-driven, Oral Lp(a) Inhibitor, as PCC for Management of Cardiovascular Risks

generative chemistry platform, which integrates more than 40 carefully selected models and multiple supporting application modules. First, Insilico's R&D team uploaded the crystal structure of the target–small molecule complex to the platform to analyze key binding sites and interaction patterns in detail.

More news about: Insilico Medicine


Aug 12, 2026, 08:30 ET Neurocrine Biosciences Announces Publication of KINECT-PRO™ Findings Demonstrating INGREZZA® (valbenazine) Capsules Improved Patient-Reported Quality of Life and Daily Functioning for People Living with Tardive Dyskinesia

Visual Analogue Scale and the Sheehan Disability Scale The EQ Visual Analogue Scale (EQ-VAS) is the second component of the 5-level EQ 5D (EQ-5D-5L). The EQ-VAS is a visual scale ranging from 0 "the worst health you can imagine" to 100 "the best health you can imagine" that assesses a patient's

More news about: Neurocrine Biosciences, Inc.


Aug 12, 2026, 08:17 ET Ivonescimab Plus Chemotherapy Approved for First-Line Squamous NSCLC; HARMONi-6 Establishes New Gold Standard in Lung Cancer Treatment

best-in-class innovative biological medicines. Founded in 2012, Akeso has built a comprehensive R&D innovation ecosystem anchored by its proprietary Tetrabody antibody technology platform, AI-powered drug R&D platform, Dual-Shield ADC technology platform, Dual-Lock T-cell engager (TCE) technology platform,

More news about: Akeso, Inc.


Aug 12, 2026, 08:12 ET TuMeke Launches Coaching Cues, Bringing Instant, AI-Powered Guidance Into Ergonomic Assessments

ergonomics, helping organizations identify and reduce workplace musculoskeletal injury risk. Its computer vision platform turns job video into automated 3D ergonomic assessments and actionable recommendations, with no wearables, sensors, or specialized equipment required. TuMeke enables safety and ergonomics

More news about: TuMeke, Inc.


Aug 12, 2026, 08:01 ET Japan and Mexico Patent Offices Both Grant Acurx Pharmaceuticals New Patents for DNA Polymerase IIIC Inhibitor Antibiotics

Gram+ specific bacterial enzyme DNA polymerase IIIC (pol IIIC), inhibiting DNA replication and leading to Gram-positive bacterial cell death. Its R&D pipeline includes antibiotic product candidates that target Gram-positive bacteria, including Clostridioides difficile, methicillin- resistant Staphylococcus

More news about: Acurx Pharmaceuticals, Inc.


Aug 12, 2026, 07:12 ET CGTN Español: Innovación en Shenzhen: conectando China con la región de Asia-Pacífico

antes no podían acceder fácilmente a la IA industrial se beneficien de ella. Esa es, sin duda, la tendencia de futuro", djio Shi Xiaoliang, director de I+D de Productos de SmartMore.Y en APEC China 2026, con la innovación entre las prioridades de la región, Shenzhen mostrará cómo su tecnología y su

More news about: CGTN Español


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.